Edges in Network
| Network | GSE16446_top500tf - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | MEF2C |
| Upstream (Parents) |
|---|
| (<<) HOXA3 → MEF2C |
| (<<) ZFPM2 → MEF2C |
| (<<) FLI1 → MEF2C |
| (<<) EBF1 → MEF2C |
| (<<) C5orf41 → MEF2C |
| (<<) ERG → MEF2C |
| (<<) LEF1 → MEF2C |
| (<<) CREBL2 → MEF2C |
| (<<) NR3C1 → MEF2C |
| Downstream (Children) |
|---|
| MEF2C → HOPX (>>) |
| MEF2C → HOXA5 (>>) |
| MEF2C → MAF (>>) |
| MEF2C → HLF (>>) |
| MEF2C → FOXF2 (>>) |
| MEF2C → SCML1 (>>) |
| MEF2C → MECOM (>>) |
| MEF2C → HOXA2 (>>) |
| MEF2C → TCF4 (>>) |
| MEF2C → PPARG (>>) |
| MEF2C → EPAS1 (>>) |
| MEF2C → ETS1 (>>) |
| MEF2C → CREB3L2 (>>) |
| MEF2C → BARX1 (>>) |
| MEF2C → GTF2H4 (>>) |
| MEF2C → PURB (>>) |
| MEF2C → FOXO1 (>>) |
| MEF2C → CLOCK (>>) |
| MEF2C → GATAD2A (>>) |
